✦ LIBER ✦

Primary chemotherapy for locally advanced breast cancer — early results of a randomized trial and implications for breast conservation

✍ Scribed by P.M. Cannon; A.R. Dixon; J.F.R. Robertson; S.Y. Chan; R.W. Blamey

Book ID: 113404282
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 316 KB
Volume: 2
Category: Article
ISSN: 0960-9776
DOI: 10.1016/0960-9776(93)90082-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary radiotherapy and chemotherapy fo

Primary radiotherapy and chemotherapy for locally advanced breast cancer

✍ Mark C. Rounsaville 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Primary chemotherapy for early and advan

Primary chemotherapy for early and advanced breast cancer

✍ Hortobagyi, Gabriel N.; Buzdar, Aman U.; Strom, Eric A.; Ames, Frederick C.; Sin 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 690 KB

Breast Conservation Following Induction

Breast Conservation Following Induction Chemotherapy for Locally Advanced Breast Cancer: A Personal Experience

✍ Gordon F. Schwartz 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

Primary chemotherapy and radiosurgical b

Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers

✍ Gilles Calais; Philippe Descamps; Sophie Chapet; Véronique Turgeon; Vés Reynaud- 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 682 KB

Polychemotherapy for Early Breast Cancer

Polychemotherapy for Early Breast Cancer: Results from the International Adjuvant Breast Cancer Chemotherapy Randomized Trial

✍ Denlinger, C.S.; Goldstein, L.J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Taxanes as primary chemotherapy for earl

Taxanes as primary chemotherapy for early breast cancer : Meta-analysis of randomized trials

✍ Federica Cuppone; Emilio Bria; Paolo Carlini; Michele Milella; Alessandra Felici 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

## Abstract ## BACKGROUND. In patients with locally advanced and operable breast cancer, neoadjuvant chemotherapy has been demonstrated to increase the chance of breast‐conserving surgery (BCS) when compared with adjuvant treatment; moreover, patients who achieve a pathologic complete response (pC